INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 11 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $578,000 | +27.9% | 600,000 | 0.0% | 0.28% | +15.6% |
| Q4 2017 | $452,000 | -2.0% | 600,000 | 0.0% | 0.24% | -15.0% |
| Q3 2017 | $461,000 | +24.9% | 600,000 | 0.0% | 0.29% | +8.7% |
| Q2 2017 | $369,000 | -0.8% | 600,000 | 0.0% | 0.26% | -16.5% |
| Q1 2017 | $372,000 | -39.8% | 600,000 | 0.0% | 0.32% | -42.0% |
| Q4 2016 | $618,000 | -22.2% | 600,000 | 0.0% | 0.54% | -1.8% |
| Q3 2016 | $794,000 | – | 600,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 9,700,000 | $10,181,000 | 2.02% |
| Telemetry Investments, L.L.C. | 1,000,000 | $1,040,000 | 0.59% |
| DAFNA Capital Management LLC | 600,000 | $618,000 | 0.54% |
| Bruce & Co., Inc. | 2,000,000 | $2,080,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 5,700,000 | $5,928,000 | 0.29% |
| Orbimed Advisors | 7,000,000 | $7,354,000 | 0.09% |
| Baker Brothers Advisors | 5,000,000 | $5,167,000 | 0.05% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,000,000 | $2,044,000,000 | 0.04% |
| Citadel Advisors | 15,000,000 | $15,394,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,000,000 | $1,033,000 | 0.01% |